SCHEMBL1744623

SCHEMBL1744623

COc1ccc(-c2c(C)cccc2C)cc1CO

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.53
PDCD1 Q15116 2/20 0.50
CD274 Q9NZQ7 2/20 0.50
PDE4A P27815 2/20 0.46
PDE4B Q07343 2/20 0.46
PDE4C Q08493 2/20 0.46
PDE4D Q08499 2/20 0.46
PDE5A O76074 1/20 0.46
PDE1A P54750 1/20 0.46
PDE1B Q01064 1/20 0.46
PDE3B Q13370 1/20 0.46
PDE1C Q14123 1/20 0.46
PDE3A Q14432 1/20 0.46
S1PR1 P21453 1/20 0.41
KDM4E B2RXH2 2/20 0.40
HPGD P15428 2/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
ALDH1A1 P00352 2/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11292098 0.79 KDM4E (0.54) PDE4AKDM4EALDH1A1HSD17B10QPCT
SCHEMBL2020335 0.79 FFAR1 (0.39) FFAR1PDCD1CD274S1PR1
SCHEMBL27965221 0.78 KDM4E (0.55) PDCD1CD274PDE4APDE4BPDE4C
SCHEMBL12577815 0.78 GRIA1 (0.42) FFAR1PDCD1CD274S1PR1
SCHEMBL13220234 0.78 PDCD1 (0.46) PDCD1CD274PDE4APDE4BPDE4C
SCHEMBL12577894 0.77 GCGR (0.46) FFAR1PDCD1CD274
SCHEMBL28008454 0.75 PDCD1 (0.55) PDCD1CD274KDM4EHPGDMAPT
SCHEMBL697285 0.73 ACHE (0.56) PDCD1CD274PDE4APDE4BPDE4C
SCHEMBL11282919 0.73 KDM4E (0.51) PDE4AKDM4EALDH1A1HSD17B10QPCT
SCHEMBL31667846 0.73 ALDH1A1 (0.68) KDM4EHPGDGAAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1559422-B1 RECEPTOR FUNCTION CONTROLLING AGENT TAKEDA PHARMACEUTICAL (JP) 2014-04-30 EP disclosed
EP-2385032-A1 GPR40 Receptor function regulator Takeda Pharmaceutical Company Limited (JP) 2011-11-09 EP disclosed
US-7960369-B2 Receptor function regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-06-14 US disclosed
US-20090012093-A1 Receptor Function Regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-01-08 US disclosed
EP-1559422-A1 RECEPTOR FUNCTION CONTROLLING AGENT Takeda Pharmaceutical Company Limited (JP) 2005-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012093-A1 Receptor Function Regulator GPR119, GIPR, INSR FFAR1 33/4885PDCD1 4372/4885CD274 3737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.